Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 3 results out of 3
Data Insights
LY-3857210 by Eli Lilly and Co for Diabetic Neuropathic Pain: Likelihood of Approval
LY-3857210 is under clinical development by Eli Lilly and Co and currently in Phase II for Diabetic Neuropathic Pain. According...
Data Insights
LY-3857210 by Eli Lilly and Co for Osteoarthritis Pain: Likelihood of Approval
LY-3857210 is under clinical development by Eli Lilly and Co and currently in Phase II for Osteoarthritis Pain. According to...
Data Insights
LY-3857210 by Eli Lilly and Co for Chronic Low Back Pain (CLBP): Likelihood of Approval
LY-3857210 is under clinical development by Eli Lilly and Co and currently in Phase II for Chronic Low Back Pain...